Company Filing History:
Years Active: 2012
Title: Michael Mamounas: Innovator in Protein Kinase Inhibitors
Introduction
Michael Mamounas is a notable inventor based in Oakland, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with therapeutic potential. His work focuses on creating innovative solutions for complex medical challenges.
Latest Patents
One of Michael Mamounas's key inventions is a patent for dihydropyridine derivatives that serve as protein kinase inhibitors. This invention provides novel dihydropyridine derivatives of the formula I, which exhibit protein tyrosine kinase inhibitory activity. The patent outlines a process for the manufacture of these compounds and their use in treating c-Met-mediated diseases or conditions. He holds 1 patent related to this groundbreaking work.
Career Highlights
Michael Mamounas is currently associated with Bayer Intellectual Property GmbH, where he continues to advance his research and development efforts. His expertise in medicinal chemistry and innovative thinking has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including Marc Adler and Stefan Baeurle. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Michael Mamounas exemplifies the spirit of innovation in the field of medicinal chemistry. His contributions, particularly in the development of protein kinase inhibitors, highlight the importance of research in addressing medical challenges. His work continues to inspire future advancements in the pharmaceutical industry.